Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives

In the last decade, antibody-drug conjugates (ADCs), normally formed by a humanized antibody and a small drug via a chemical cleavable or non-cleavable linker, have emerged as a potential treatment strategy in cancer disease. They allow to get a selective delivery of the chemotherapeutic agents at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Sabroso, Cristina, Lozza, Irene, Torres-Suárez, Ana Isabel, Fraguas-Sánchez, Ana Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541375/
https://www.ncbi.nlm.nih.gov/pubmed/34683998
http://dx.doi.org/10.3390/pharmaceutics13101705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541375/
https://www.ncbi.nlm.nih.gov/pubmed/34683998
http://dx.doi.org/10.3390/pharmaceutics13101705

Ejemplares similares